Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries (Q30566518)

20 August 2017

Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries (English)

1 reference

20 August 2017

Jacob Creswell

1

0 references

Sayera Banu

object named as

Sayera Banu

10

0 references

author name string

Andrew J Codlin

2

1 reference

20 August 2017

Emmanuel Andre

3

1 reference

20 August 2017

Mark A Micek

4

1 reference

20 August 2017

Ahmed Bedru

5

1 reference

20 August 2017

E Jane Carter

6

1 reference

20 August 2017

Rajendra-Prasad Yadav

7

1 reference

20 August 2017

Andrei Mosneaga

8

1 reference

20 August 2017

Bishwa Rai

9

1 reference

20 August 2017

Miranda Brouwer

11

1 reference

20 August 2017

Lucie Blok

12

1 reference

20 August 2017

Suvanand Sahu

13

1 reference

20 August 2017

Lucica Ditiu

14

1 reference

20 August 2017

2 January 2014

1 reference

20 August 2017

BMC Infectious Diseases

1 reference

20 August 2017

14

1 reference

20 August 2017

2

1 reference

Creative Commons Attribution 2.0 Generic

20 August 2017

start time

2 January 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2334-14-2

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Novel methodology to assess sputum smear microscopy quality in private laboratories

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Point-of-care diagnosis of tuberculosis: past, present and future

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

The diagnostic performance of the GenoType MTBDRplus version 2 line probe assay is equivalent to that of the Xpert MTB/RIF assay

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Promise versus reality: optimism bias in package inserts for tuberculosis diagnostics

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Xpert MTB/RIF assay for diagnosis of pleural tuberculosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

GeneXpert--a game-changer for tuberculosis control?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Rapid molecular detection of tuberculosis and rifampin resistance

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

In reply to 'Should Xpert® MTB/RIF be rolled out in low-income countries?' [Correspondence].

20 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-2

Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-2

Are peripheral microscopy centres ready for next generation molecular tuberculosis diagnostics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-2

The ethics of national tuberculosis programmes in low-income countries not rolling out Xpert ® MTB/RIF

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3898850

Tuberculosis Diagnosis — Time for a Game Change

26 November 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-14-2

An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24383553

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Rapid diagnosis of pediatric intrathoracic tuberculosis from stool samples using the Xpert MTB/RIF Assay: a pilot study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24383553

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Should Xpert® MTB/RIF be rolled out in low-income countries?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24383553

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2334-14-2

1 reference

Dimensions Publication ID

20 August 2017

0 references

1 reference

20 August 2017

1 reference